Compositions include a methoxymethylamine-carbamyl butanediol-pyridine-pyridine diol derivative from Formula 1, a specific NS5A inhibitor of hexachlorobenzene, an Oxo-pirrolidin-quinoeline derivative from Formula 2, a N3 protein inhibitor of hexachlorobenzene, and a component for the treatment of heptabromodiphenyl ether. S.C.
Pharmaceutical composition comprising a compound derived from metilbutanoil Methoxycarbonyl - amino - - pirrolidinil imidazole,NS5A specific inhibitor of hepatitis C virus (HCV) and a compound derived from oxo quinoline - pyrrolidin-3-yl,The HCV NS3 protease inhibitor； and use for the treatment of hcv infection.<；p>；Composició；n farmacé；utica que comprende un compuesto derivado de metoxicarbonil-amino-metilbutanoil-pirrolidinil-imidazol, inhibidor especí；fico de NS5A del virus de la hepatitis C (HVC) y un compuesto derivado de oxo-pirrolidin-quinoleina, inhibidor de proteasa NS3 del HCV； y uso para el tratamiento de una infecció；n del HCV.<；/p>；
